APA (7th ed.) Citation

X, Y., X, M., T, Z., DR, C., EV, N., KC, C., . . . RJ, D. (2025). Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer. Nature communications, 16(1), 1871. https://doi.org/10.1038/s41467-025-57046-8

Chicago Style (17th ed.) Citation

X, Yang, et al. "Activation of CAMK2 by Pseudokinase PEAK1 Represents a Targetable Pathway in Triple Negative Breast Cancer." Nature Communications 16, no. 1 (2025): 1871. https://doi.org/10.1038/s41467-025-57046-8.

MLA (9th ed.) Citation

X, Yang, et al. "Activation of CAMK2 by Pseudokinase PEAK1 Represents a Targetable Pathway in Triple Negative Breast Cancer." Nature Communications, vol. 16, no. 1, 2025, p. 1871, https://doi.org/10.1038/s41467-025-57046-8.